5‐HT1A receptor agonist‐antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems
Open Access
- 1 July 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (5) , 1108-1114
- https://doi.org/10.1038/sj.bjp.0703394
Abstract
It has been reported that radiolabelled agonist : antagonist binding affinity ratios can predict functional efficacy at several different receptors. This study investigates whether this prediction is true for recombinant and native tissue 5‐HT1A receptors. Saturation studies using [3H]‐8‐OH‐DPAT and [3H]‐MPPF revealed a single, high affinity site (KD∼1 nM) in HEK293 cells expressing human 5‐HT1A receptors and rat cortex. In recombinant cells, [3H]‐MPPF labelled 3–4 fold more sites than [3H]‐8‐OH‐DPAT suggesting the presence of more than one affinity state of the receptor. [3H]‐Spiperone labelled a single, lower affinity site in HEK293 cells expressing h5‐HT1A receptors but did not bind to native tissue 5‐HT1A receptors. These data suggest that, in transfected HEK293 cells, human 5‐HT1A receptors exist in different affinity states but in native rat cortical tissue the majority of receptors appear to exist in the high agonist affinity state. Receptor agonists inhibited [3H]‐MPPF binding from recombinant 5‐HT1A receptors in a biphasic manner, whereas antagonists and partial agonists gave monophasic inhibition curves. All compounds displaced [3H]‐8‐OH‐DPAT and [3H]‐spiperone binding in a monophasic manner. In rat cortex, all compounds displaced [3H]‐MPPF and [3H]‐8‐OH‐DPAT in a monophasic manner. Functional evaluation of compounds, using [35S]‐GTPγS binding, produced a range of intrinsic activities from full agonism, displayed by 5‐HT and 5‐CT to inverse agonism displayed by spiperone. [3H]‐8‐OH‐DPAT : [3H]‐MPPF pKi difference correlated well with functional intrinsic activity (r=0.86) as did [3H]‐8‐OH‐DPAT : [3H]‐spiperone pKi difference with functional intrinsic activity (r=0.96). Thus agonist : antagonist binding affinity differences may be used to predict functional efficacy at human 5‐HT1A receptors expressed in HEK293 cells where both high and low agonist affinity states are present but not at native rat cortical 5‐HT1A receptors in which only the high agonist affinity state was detectable. British Journal of Pharmacology (2000) 130, 1108–1114; doi:10.1038/sj.bjp.0703394Keywords
This publication has 23 references indexed in Scilit:
- Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1and 5-HT2receptorsBritish Journal of Pharmacology, 1998
- EVIDENCE FOR THE STABILISATION OF THE HIGH-AFFINITY STATE OF β-ADRENOCEPTORS BY AN ENDOGENOUS FACTOR IN RAT BRAINPharmacological Research, 1998
- Human 5-HT1 Receptor Subtypes Exhibit Distinct G Protein Coupling Behaviors in Membranes from Sf9 CellsBiochemistry, 1997
- The two-state model of receptor activationTrends in Pharmacological Sciences, 1995
- Species differences in the distribution of central 5-HT1 binding sites: a comparative autoradiographic study between rat and guinea pigBrain Research, 1991
- A1 Adenosine Receptor‐G Protein Coupling in Bovine Brain Membranes: Effects of Guanine Nucleotides, Salt, and SolubilizationJournal of Neurochemistry, 1988
- Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo‐M ratio as an index of efficacy at cortical muscarinic receptorsBritish Journal of Pharmacology, 1988
- Differential regulation of high-affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortexBiochemical and Biophysical Research Communications, 1983
- The character of the muscarinic receptors in different regions of the rat brainProceedings of the Royal Society of London. B. Biological Sciences, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973